TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Today

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 3:03 PM

Sat Aug 27

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 8:47 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:04 PM

Wed Aug 24

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 10:13 PM

Supernova Boards Post

TMFBiologyFool posted to the Supernova boards. 2:43 AM

Tue Aug 23

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 2:50 PM

Mon Aug 22

Pro Boards Post

TMFBiologyFool replied to the Pro boards. 5:13 PM

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 4:11 PM

Pro Boards Post

TMFBiologyFool replied to the Pro boards. 1:29 PM

Thu Aug 18

Pro Boards Post

TMFBiologyFool replied to the Pro boards. 8:17 PM

NL

Article

TMFBiologyFool published an article 1:20 PM

Why Oncomed Pharmaceuticals Inc's Share Price (but Not Its Valuation) Plummeted Today

The development-stage biotech raises capital, diluting shareholders in the process.

Wed Aug 17

Pro Boards Post

TMFBiologyFool replied to the Pro boards. 7:10 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 12:10 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 11:41 AM

Tue Aug 16

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:32 PM

Rule Breakers article.

TMFBiologyFool published an update. 4:03 PM

NL

Article

TMFBiologyFool published an article 3:48 PM

Ionis Pharmaceuticals Inc Begins to Shift Focus

With clinical trial data in hand, management highlights the steps remaining to get nusinersen on the market.

NL

Article

TMFBiologyFool published an article 2:30 PM

Novo Nordisk A/S Focuses on New Drugs

Pricing pressure hampers the drugmaker's older insulin drugs.

Stock Advisor article.

TMFBiologyFool published an update. 12:26 PM

Mon Aug 15

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 7:08 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 87.11
Player Rank 9663 out of 74933
Score 633.77
Score Change Today +22.37
Accuracy 67.62%
Active Picks 73
Total Picks 215
Best Pick MNKD (+235.52)
Worst Pick INCY (-733.28)
Average Score per Pick 2.95
Charms Earned 10
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1288
Recs Received 1904
People who have rec'd these posts 603
Recs to Posts Ratio (last 30 days) 4.40
Threads Started 137
Threads Started Percentage 10.64 %
Most Frequent Board Motley Fool Supernova
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 55.43 %
Show TMFBiologyFool’s 10 Latest Posts